Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19846279rdf:typepubmed:Citationlld:pubmed
pubmed-article:19846279lifeskim:mentionsumls-concept:C0040615lld:lifeskim
pubmed-article:19846279lifeskim:mentionsumls-concept:C0041004lld:lifeskim
pubmed-article:19846279lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:19846279lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:19846279lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:19846279lifeskim:mentionsumls-concept:C1537647lld:lifeskim
pubmed-article:19846279lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:19846279lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:19846279lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:19846279lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:19846279lifeskim:mentionsumls-concept:C0007064lld:lifeskim
pubmed-article:19846279pubmed:issue2-3lld:pubmed
pubmed-article:19846279pubmed:dateCreated2009-11-13lld:pubmed
pubmed-article:19846279pubmed:abstractTextAcetyl-coenzyme A carboxylase alpha (ACACA) single-nucleotide polymorphism (SNP) (rs2229416) was significantly associated with hypertriglyceridemia, during exploration of antipsychotic direct effects on lipids. Neuropeptide Y (NPY) gene (rs1468271) and ACACB gene (rs2241220) SNPs were significantly associated with severe hypercholesterolemia. In the same sample (173 patients on olanzapine, quetiapine, chlorpromazine or mirtazapine [increasing the risk of hyperlipidemia] and 184 controls taking other antipsychotics), three (rs1266175, rs12453407 and rs9906543) of eight additional ACACA SNPs were significantly associated with hypertriglyceridemia in those taking drugs of interest, but not in controls. Five other ACACA SNPs, three additional NPY SNPs, and seven additional ACACB SNPs were not significant.lld:pubmed
pubmed-article:19846279pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846279pubmed:languageenglld:pubmed
pubmed-article:19846279pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846279pubmed:citationSubsetIMlld:pubmed
pubmed-article:19846279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846279pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19846279pubmed:statusMEDLINElld:pubmed
pubmed-article:19846279pubmed:monthDeclld:pubmed
pubmed-article:19846279pubmed:issn1573-2509lld:pubmed
pubmed-article:19846279pubmed:authorpubmed-author:de LeonJoseJlld:pubmed
pubmed-article:19846279pubmed:authorpubmed-author:ArranzMaria...lld:pubmed
pubmed-article:19846279pubmed:authorpubmed-author:DiazFrancisco...lld:pubmed
pubmed-article:19846279pubmed:authorpubmed-author:WindemuthAndr...lld:pubmed
pubmed-article:19846279pubmed:authorpubmed-author:RuañoGualbert...lld:pubmed
pubmed-article:19846279pubmed:authorpubmed-author:MearyAlexande...lld:pubmed
pubmed-article:19846279pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19846279pubmed:volume115lld:pubmed
pubmed-article:19846279pubmed:ownerNLMlld:pubmed
pubmed-article:19846279pubmed:authorsCompleteYlld:pubmed
pubmed-article:19846279pubmed:pagination136-40lld:pubmed
pubmed-article:19846279pubmed:dateRevised2011-3-3lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:meshHeadingpubmed-meshheading:19846279...lld:pubmed
pubmed-article:19846279pubmed:year2009lld:pubmed
pubmed-article:19846279pubmed:articleTitleAcetyl-coenzyme A carboxylase alpha gene variations may be associated with the direct effects of some antipsychotics on triglyceride levels.lld:pubmed
pubmed-article:19846279pubmed:affiliationDepartment of Biostatistics, Kansas University Medical School, Kansas City, Kansas, United States.lld:pubmed
pubmed-article:19846279pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:31entrezgene:pubmedpubmed-article:19846279lld:entrezgene
entrez-gene:32entrezgene:pubmedpubmed-article:19846279lld:entrezgene
entrez-gene:4852entrezgene:pubmedpubmed-article:19846279lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19846279lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19846279lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19846279lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19846279lld:entrezgene